Concepedia

Ihab Girgis

IG

30

Publications

1.8K

Citations

21

H-Index

1983

Active since

Affiliations

Princeton University(Current)

Bristol-Myers Squibb (United States)

University of Miami

TU Wien

Beth Israel Deaconess Medical Center

Ihab Girgis is an author at Princeton University specializing in engineering, fluid mechanics, and aerodynamics.

Top concepts

Publications per year

1983–2024

30

Publications

30

Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

Kim Papp, Kenneth B. Gordon, Diamant Thaçi et al. · New England Journal of Medicine · 2018 · 400 citations · Full text

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*

Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende et al. · Critical Care Medicine · 2019 · 222 citations · Full text

Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende et al. · Intensive Care Medicine · 2019 · 177 citations · Full text

, , +6

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors

Anjaneya Chimalakonda, James R. Burke, Lihong Cheng et al. · Dermatology and Therapy · 2021 · 118 citations · Full text

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non‐valvular atrial fibrillation: Results from ROCKET AF

Ihab Girgis, Manesh R. Patel, Gary Peters et al. · The Journal of Clinical Pharmacology · 2014 · 106 citations

Rows per page

1–5 of 30